Substance use among patients in specialized mental health services in Norway: prevalence and patient characteristics based on a national census

References

• Kessler RC. Impact of substance abuse on the diagnosis, course, and treatment of mood disorders: the epidemiology of dual diagnosis. Biol Psychiatry. 2004;56:730–737.
   PubMed Web of Science ®Google Scholar
• Lai HMX, Cleary M, Sitharthan T, et al. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: a systematic review and meta-analysis. Drug Alcohol Depend. 2015;154:1–13.
   PubMed Web of Science ®Google Scholar
• Toftdahl NG, Nordentoft M, Hjorthøj C. Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study. Soc Psychiatry Psychiatr Epidemiol. 2016;51(1):129–140.
   PubMed Web of Science ®Google Scholar
• Nesvåg R, Knudsen GP, Bakken IJ, et al. Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based study. Soc Psychiatry Psychiatr Epidemiol. 2015;50(8):1267–1276.
   PubMed Web of Science ®Google Scholar
• Petersen SM, Toftdahl NG, Nordentoft M, et al. Schizophrenia is associated with increased risk of subsequent substance abuse diagnosis: a nation‐wide population‐based register study. Addiction. 2019;114(12):2217–2226.
   PubMed Web of Science ®Google Scholar
• Di Florio A, Craddock N, van den Bree M. Alcohol misuse in bipolar disorder. A systematic review and meta-analysis of comorbidity rates. Eur Psychiatry. 2014;29(3):117–124.
   PubMed Web of Science ®Google Scholar
• Helseth V, Lykke-Enger T, Johnsen J, et al. Substance use disorders among psychotic patients admitted to inpatient psychiatric care. Nord J Psychiatry. 2009;63(1):72–77.
   PubMed Web of Science ®Google Scholar
• Hunt GE, Large MM, Cleary M, et al. Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: systematic review and meta-analysis. Drug Alcohol Depend. 2018;191(1):234–258.
   PubMedGoogle Scholar
• Kavanagh DJ, Waghorn G, Jenner L, et al. Demographic and clinical correlates of comorbid substance use disorders in psychosis: multivariate analyses from an epidemiological sample. Schizophr Res. 2004;66(2–3):115–124.
   PubMed Web of Science ®Google Scholar
• Messer T, Lammers G, Müller-Siecheneder F, et al. Substance abuse in patients with bipolar disorder: a systematic review and meta-analysis. Psychiatry Res. 2017;253:338–350.
   PubMed Web of Science ®Google Scholar
• Fløvig JC, Vaaler AE, Morken G. Substance use at admission to an acute psychiatric department. Nord J Psychiatry. 2009;63(2):113–119.
   PubMed Web of Science ®Google Scholar
• Helseth V, Samet S, Johnsen J, et al. Independent or substance-induced mental disorders? An investigation of comorbidity in an acute psychiatric unit. J. Dual Diagn. 2013;9(1):78–86.
   Web of Science ®Google Scholar
• Jané-Llopis E, Matytsina I. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev. 2006;25(6):515–536.
   PubMed Web of Science ®Google Scholar
• Rush B, Koegl CJ. Prevalence and profile of people with co-occurring mental and substance use disorders within a comprehensive mental health system. Can J Psychiatry. 2008;53(12):810–821.
   PubMed Web of Science ®Google Scholar
• Wüsthoff LE, Waal H, Ruud T, et al. A cross-sectional study of patients with and without substance use disorders in community mental health centres. BMC Psychiatry. 2011;11:93.
   PubMed Web of Science ®Google Scholar
• Mueser KT, Yarnold PR, Rosenberg SD, et al. Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. Schizophr Bull. 2000;26(1):179–192.
   PubMed Web of Science ®Google Scholar
• Clausen H, Ruud T, Odden S, et al. Hospitalisation of severely mentally ill patients with and without problematic substance use before and during assertive community treatment: an observational cohort study. BMC Psychiatry. 2016;16(1):125.
   PubMedGoogle Scholar
• Ose SO, Lilleeng S, Pettersen I, et al. Risk of violence among patients in psychiatric treatment: results from a national census. Nord J Psychiatry. 2017;71(8):551–560.
   PubMed Web of Science ®Google Scholar
• Rund BR. A review of factors associated with severe violence in schizophrenia. Nord J Psychiatry. 2018;72(8):561–571.
   PubMed Web of Science ®Google Scholar
• Reininghaus U, Dutta R, Dazzan P, et al. Mortality in schizophrenia and other psychoses: a 10-year follow-up of the ӔSOP first-episode cohort. Schizophr Bull. 2015;41(3):664–673.
   PubMed Web of Science ®Google Scholar
• van Dijk D, Koeter MW, Hijman R, et al. Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study. Schizophr Res. 2012;137(1–3):50–57.
   PubMed Web of Science ®Google Scholar
• van Wamel A, van Rooijen S, Kroon H. 2015. Intergrated tretament: the model and European Experiences. In: Dom G, Moggi F, editors. Co-occurring addicitive and psyschiatric disorders. Heidelberg, Berlin: Springer, pp 28–45.
   Google Scholar
• Lindahl AK. 2016. The Norwegian health care system, 2015. In: Mossialos E, Wentzl M, Osborn R, Sarak D, editors. International profiles of health care systems, 2015. New York (NY): The Commonwealth Fund; p. 133–141.
   Google Scholar
• Norwegian Directorate of Health. 2011. [National guidelines for assessment, treatment and follow-up people with concomitant substance abuse and mental illness]. Oslo (Norway): Norwegian Directorate of Health. Norwegian.
   Google Scholar
• Burns JK. Pathways from cannabis to psychosis: a review of the evidence. Front Psychiatry. 2013;4:128.
   PubMedGoogle Scholar
• Cerdá M, Sagdeo A, Galea S. Comorbid forms of psychopathology: key patterns and future research directions. Epidemiol Rev. 2008;30(1):155–177.
   PubMed Web of Science ®Google Scholar
• Torvik FA, Rosenström TH, Gustavson K, et al. Explaining the association between anxiety disorders and alcohol use disorder: a twin study. Depress Anxiety. 2019;36(6):511–522.
   PubMed Web of Science ®Google Scholar
• Ikeda M, Okahisa Y, Aleksic B, et al. Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia. Neuropsychopharmacology. 2013;38(10):1864–1870.
   PubMed Web of Science ®Google Scholar
• Khokhar JY, Dwiel LL, Henricks AM, et al. The link between schizophrenia and substance use disorder: a unifying hypothesis. Schizophr Res. 2018;194:78–85.
   PubMed Web of Science ®Google Scholar
• Green AI, Tohen MF, Hamer RM, et al. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. Schizophr Res. 2004;66(2–3):125–135.
   PubMed Web of Science ®Google Scholar
• Robinson J, Sareen J, Cox BJ, et al. Self-medication of anxiety disorders with alcohol and drugs: results from a nationally representative sample. J Anxiety Disord. 2009;23(1):38–45.
   PubMed Web of Science ®Google Scholar
• Turner S, Mota N, Bolton J, et al. Self-medication with alcohol or drugs for mood and anxiety disorders: a narrative review of the epidemiological literature. Depress Anxiety. 2018;35(9):851–860.
   PubMed Web of Science ®Google Scholar
• Chung RK, Large MM, Starmer GA, et al. The reliability of reports of recent psychoactive substance use at the time of admission to an acute mental health unit. J Dual Diagn. 2009;5(3–4):392–403.
   Web of Science ®Google Scholar
• Hansen SS, Munk-Jørgensen P, Guldbaek B, et al. Psychoactive substance use diagnoses among psychiatric in-patients. Acta Psychiatr Scand. 2000;102(6):432–438.
   PubMed Web of Science ®Google Scholar
• Sundström C, Petersén E, Sinadinovic K, et al. Identification and management of alcohol use and illicit substance use in outpatient psychiatric clinics in Sweden: a national survey of clinic directors and staff. Addict Sci Clin Pract. 2019;14(1):10.
   PubMedGoogle Scholar
• Wüsthoff LE, Waal H, Ruud T, et al. Identifying co-occurring substance use disorders in community mental health centres. Tailored approaches are needed. Nord J Psychiatry. 2011;65(1):58–64.
   PubMed Web of Science ®Google Scholar
• Norwegian Board of Health. 2019. Oppsummering av landsomfattende tilsyn i 2017-2018 med spesialisthelsetjenster for pasienter med psykiske lidelser og mulig samtidig ruslidelse. (Summary of Resport of the Norwegian Board of Health Supervision). Rapport fra Helsetilsynet, 7/2019. ISBN:978-82-93595-25-0. www.helsetilsynet.no
   Google Scholar
• Gilchrist G, Moskalewicz J, Slezakova S, et al. Staff regard towards working with substance users: a European multi-centre study. Addiction. 2011;106(6):1114–1125.
   PubMed Web of Science ®Google Scholar